Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Paul Klenerman, Prinicipal Investigator

paul-klenerman-thumb.jpgInfectious diseases such as HIV, hepatitis B and C, affect hundreds of millions of people worldwide. Our group works on the immune response to these infections, focusing on both the host and the pathogen. As there is currently no vaccine to prevent hepatitis C infection, many of our projects have addressed aspects of chronic hepatitis C virus (HCV) infection and vaccine responses. In addition, our group also looks at a range of viruses and bacteria. Overall our main contributions to date have been to define mechanisms of viral persistence, including: T cell escape, antagonism, original antigen sin, integration of non-retroviral RNA viruses; to define the key features of successful immune responses against HCV, leading to trials of a T cell vaccine; and to define the distinctive CD161+ T cell population, which dominates in the human liver.


Translational Gastroenterology Unit Experimental Medicine Division Nuffield Dept Clinical Medicine University of Oxford John Radcliffe Hospital Headington, Oxford OX3 9DU  
Phone: +44 (0)1865 220137  
The Weatherall Institute of Molecular Medicine University of Oxford John Radcliffe Hospital Headington, Oxford OX3 9DS  
Phone: +44 (0)1865 222443 Fax: +44 (0)1865 222737

Our team